Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Rating of "Hold" from Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS - Get Free Report) have been given an average recommendation of "Hold" by the five brokerages that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $111.50.

Several equities research analysts have weighed in on TRNS shares. StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a research report on Wednesday, February 5th. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Northland Securities reiterated a "market perform" rating and issued a $85.00 target price (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Finally, HC Wainwright cut their price objective on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a report on Wednesday, January 29th.

Insider Buying and Selling

In other Transcat news, Director Craig D. Cairns acquired 1,200 shares of the business's stock in a transaction that occurred on Friday, January 31st. The stock was purchased at an average cost of $77.02 per share, with a total value of $92,424.00. Following the transaction, the director now owns 1,910 shares of the company's stock, valued at $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 2.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Transcat

Large investors have recently made changes to their positions in the stock. Rhumbline Advisers lifted its stake in Transcat by 6.2% during the first quarter. Rhumbline Advisers now owns 13,110 shares of the scientific and technical instruments company's stock worth $976,000 after purchasing an additional 762 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Transcat by 10,137.5% during the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock valued at $122,000 after acquiring an additional 1,622 shares during the period. Moody National Bank Trust Division increased its stake in Transcat by 30.5% during the 1st quarter. Moody National Bank Trust Division now owns 13,355 shares of the scientific and technical instruments company's stock worth $994,000 after buying an additional 3,120 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Transcat by 24.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,029 shares of the scientific and technical instruments company's stock worth $1,801,000 after buying an additional 3,307 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC grew its stake in shares of Transcat by 39.7% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 62,892 shares of the scientific and technical instruments company's stock worth $6,650,000 after acquiring an additional 17,859 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Down 1.7 %

NASDAQ:TRNS traded down $1.39 during mid-day trading on Friday, hitting $81.74. 25,449 shares of the company's stock traded hands, compared to its average volume of 100,184. The company has a market capitalization of $760.87 million, a P/E ratio of 44.18 and a beta of 0.67. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The company has a fifty day moving average of $76.83 and a 200 day moving average of $96.22. Transcat has a twelve month low of $67.56 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the prior year, the firm posted $0.56 EPS. On average, analysts forecast that Transcat will post 2.3 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.